Back to Search
MARKUS BREDEL, MD PHD
MD PHD
Radiation Oncology Physician
NPI: 1912226267IndividualAccepts Medicare
Specialties, Licenses & Credentials
Radiation Oncology PhysicianPrimary
Radiology — Radiation Oncology
Code: 2085R0001X
33142(AL)ME169665(FL)
CMS Specialties
PrimaryRADIATION ONCOLOGY
Education
OTHER
Class of 2001
Research & Publications (20)
Translating biological insights into clinical endpoints in neuro-oncology.
PMID 19628430·Lancet Oncol·2009
8-other
Monosomy of chromosome 10 associated with dysregulation of epidermal growth factor signaling in glioblastomas.
PMID 19602687·JAMA·2009
8-other
A network model of a cooperative genetic landscape in brain tumors.
PMID 19602686·JAMA·2009
4-observational
Nomograms as clinicobiological predictors of survival in glioblastoma.
PMID 18177813·Lancet Oncol·2008
2-rct
Integrated high-resolution genome-wide analysis of gene dosage and gene expression in human brain tumors.
PMID 17634618·Methods Mol Biol·2007
6-review
Tumor necrosis factor-alpha-induced protein 3 as a putative regulator of nuclear factor-kappaB-mediated resistance to O6-alkylating agents in human glioblastomas.
PMID 16365179·J Clin Oncol·2006
8-other
Functional network analysis reveals extended gliomagenesis pathway maps and three novel MYC-interacting genes in human gliomas.
PMID 16204036·Cancer Res·2005
8-other
High-resolution genome-wide mapping of genetic alterations in human glial brain tumors.
PMID 15899798·Cancer Res·2005
8-other
Amplification of whole tumor genomes and gene-by-gene mapping of genomic aberrations from limited sources of fresh-frozen and paraffin-embedded DNA.
PMID 15858140·J Mol Diagn·2005
8-other
DNA topoisomerase IIalpha and Her-2/neu gene dosages in pediatric malignant gliomas.
PMID 15809708·Int J Oncol·2005
8-other
Chemogenomics: an emerging strategy for rapid target and drug discovery.
PMID 15131650·Nat Rev Genet·2004
6-review
Genomics-based hypothesis generation: a novel approach to unravelling drug resistance in brain tumours?
PMID 14761812·Lancet Oncol·2004
6-review
Vascular patterns in glioblastoma influence clinical outcome and associate with variable expression of angiogenic proteins: evidence for distinct angiogenic subtypes.
PMID 12744467·Brain Pathol·2003
4-observational
Predicting outcome and tailoring treatment in high-grade gliomas.
PMID 12732162·Lancet Oncol·2003
8-other
DNA topoisomerase IIalpha predicts progression-free and overall survival in pediatric malignant non-brainstem gliomas.
PMID 12115482·Int J Cancer·2002
8-other
High expression of DNA topoisomerase IIalpha and Ki-67 antigen is associated with prolonged survival in glioblastoma patients.
PMID 12091064·Eur J Cancer·2002
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 1700 6TH AVE S, HAZELRIG - SALTER RADIATION ONCOLOGY CENTER
BIRMINGHAM, AL 35233 - Phone
- (205) 934-5670
Quick Facts
- NPI
- 1912226267
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 25
- Publications
- 20
Are you this provider?
Claim Your Profile